JI
Congress trade
Sen. James Inhofe (R-OK) bought $50K-$100K of Celgene Corporation (CELG) stock
James Inhofe, U.S. Senator (R-OK), disclosed a purchase of Celgene Corporation (CELG) stock worth $50K-$100K in a STOCK Act filing on Feb 26, 2018.
The trade happened on Feb 22, 2018, 4 days before it was made public.
- Traded
- Feb 22, 2018
- Disclosed
- Feb 26, 2018
- Filing delay
- 4 days
- Source
- STOCK Act disclosure
Other trades in this disclosure (7)
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.